Baquiran Lestrino MD is categorized under Internal Medicine Practitioners in New York City, NY and active since 1971.
Baquiran Lestrino MD was established in 1971, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Practitioners business, which does work in the B2C market, and is classified as a Internal Medicine Practitioners, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Lestrino Baquiran at the company’s single location by writing to 50 Central Park West Apartment 1a, New York City, New York NY 10023 or by phoning (212) 721-8200. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Baquiran Lestrino MD |
Contact Person: | Lestrino Baquiran |
Address: | 50 Central Park West Apartment 1a, New York City, New York 10023 |
Phone Number: | (212) 721-8200 |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 1971 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Internal Medicine Practitioners |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Baquiran Lestrino MD was started in 1971 to provide professional Internal Medicine Practitioners under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Lestrino Baquiran for inquiries that concern Baquiran Lestrino MD by calling the company number (212) 721-8200, as your correspondence is most welcome. Additionally, the physical location of the single location of Baquiran Lestrino MD can be found at the coordinates 40.771793,-73.979267 as well as the street address 50 Central Park West Apartment 1a in New York City, New York 10023.
For its online presence, you may visit Baquiran Lestrino MD’s website at and engage with its social media outlets through on Twitter and on Facebook.